Baring Asia says agrees to buy Japan drugmaker Bushu from Tokio Marine-Reuters

Hong Kong-based Baring Private Equity Asia said on Monday it has agreed to buy Japanese drugmaker Bushu Pharmaceuticals, valued at 77.3 billion yen ($668 million), from Tokio Marine Capital.

DealsNorth AmericaUSBriefs